Detalhe da pesquisa
1.
Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey.
Malar J
; 20(1): 362, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488770
2.
Risk factors associated with house entry of malaria vectors in an area of Burkina Faso with high, persistent malaria transmission and high insecticide resistance.
Malar J
; 20(1): 397, 2021 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34629053
3.
A cohort study to identify risk factors for Plasmodium falciparum infection in Burkinabe children: implications for other high burden high impact countries.
Malar J
; 19(1): 371, 2020 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33066799
4.
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.
Mol Ther
; 25(2): 547-559, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28153101
5.
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.
Mol Ther
; 24(8): 1470-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27109630
6.
Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies.
Mem Inst Oswaldo Cruz
; 108(5): 644-50, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23903982
7.
Haemoglobin variants and Plasmodium falciparum malaria in children under five years of age living in a high and seasonal malaria transmission area of Burkina Faso.
Malar J
; 11: 154, 2012 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22559271
8.
Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
Sci Rep
; 12(1): 1402, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082312
9.
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
Front Immunol
; 13: 978591, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36119062
10.
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
PLoS Med
; 8(2): e1000408, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21304925
11.
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Lancet Infect Dis
; 16(10): 1123-1133, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27430374
12.
Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).
PLoS One
; 9(9): e107965, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25238160
13.
Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
Clin Vaccine Immunol
; 21(6): 901-3, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24739980
14.
Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.
PLoS One
; 8(1): e50036, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23320064
15.
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.
PLoS One
; 8(11): e78679, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24244339
16.
Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso.
BMC Res Notes
; 5: 76, 2012 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22283984
17.
Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
PLoS One
; 6(8): e23391, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21858097
18.
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.
PLoS One
; 4(10): e7549, 2009 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19855847
19.
Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies
Mem. Inst. Oswaldo Cruz
; 108(5): 644-650, ago. 2013. tab, graf
Artigo
em Inglês
| LILACS | ID: lil-680765